BiotechTube
Home/Propanc Biopharma/James Nathanielsz
JN

James Nathanielsz

CEO and Executive Chairman

Propanc Biopharma

Therapeutic Areas

OncologySolid Tumors

Propanc Biopharma Pipeline

DrugIndicationPhase
PRPAdvanced Solid Tumors (Pancreatic, Ovarian, Colorectal)Phase 1/2

Leadership Team at Propanc Biopharma

PD
Prof. Dr. Klaus Kutz
Chief Medical Officer
DR
Dr. Ralf Brandt
Research & Development Director
JZ
Jeannine Zimmerman
Chief Financial Officer
View full Propanc Biopharma profile